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Current adjunctive psychosocial interventions for bipolar disorder (BD) aim to impact illness 
course via information sharing/skill development. This focus on clinical outcomes contrasts 
with the emergent recovery paradigm, which prioritises adaptation to serious mental illness 
and movement towards personally meaningful goals. The aim of this review is to encourage 
innovation in the psychological management of BD by considering three recovery-oriented 
trends in the literature.  First, the importance of quality of life as a target of recovery-oriented 
clinical work is considered. Second, the recent staging approach to BD is described, and we 
outline implications for psychosocial interventions tailored to stage. Finally, we review 
evidence suggesting that mindfulness-based psychosocial interventions have potential across 
early, middle and late stages of BD. It is concluded that the humanistic emphasis of the 
recovery paradigm provides a timely stimulus for development of a next generation of 
psychosocial treatments for people with BD.    
 




















Towards Recovery-oriented Psychosocial Interventions for Bipolar Disorder: 
Quality of life Outcomes, Stage-sensitive Treatments, and Mindfulness Mechanisms 
 
Over the past decade, psychosocial interventions have been shown to be effective 
adjuncts to pharmacotherapy for bipolar disorder (BD). However, effect sizes are not large, 
mechanisms are poorly understood, and more research is urgently required to improve 
outcomes for people with BD (Oud et al., 2016). The overarching aim here is to encourage 
innovation in this domain by reviewing three streams of research with potential to inform the 
next generation of psychosocial interventions for BD. The streams are linked by an emphasis 
on recovery, which is commonly defined as,  “a deeply personal, unique process of changing 
one’s attitudes, values, feelings, goals, skills and/or roles . . . a way of living a satisfying, 
hopeful and contributing life even with the limitations caused by illness” (Anthony, 1993, 
p.15).  
The paper includes five sections. First, we outline the emergent recovery framework 
in mental health and note that existing psychosocial interventions prioritise ‘clinical and 
functional’ recovery over ‘personal recovery’. Second, the aims of psychosocial treatments 
are reconsidered in the light of growing literature on subjective quality of life (QoL) in BD. 
Third, we consider data suggesting that stage of disorder is a meaningful framework in BD 
and may be an important moderator of treatment response. Fourth, growing evidence for the 
impact of mindfulness-based therapies on BD and BD-related outcomes is reviewed. 
Findings of these overlapping reviews are critically weighed in an integrative Discussion 
which outlines next steps for research and practice in recovery-oriented psychosocial 
interventions for BD.    
















Initially driven by the mental health consumer movement, the recovery perspective 
has been adopted in mental health policies and guidelines worldwide (Commonwealth of 
Australia, 2009; Department of Health, 2011; New Freedom Commission on Mental Health, 
2003). The recovery perspective has rapidly become the expressed goal of treatment for 
persons with persistent mental disorders (Song & Hsu, 2011). Indeed, recovery has so rapidly 
become instantiated in mental health guidelines throughout the western world that practice 
has arguably outpaced research (Tse et al., 2014).  
Personal recovery (contrasted with clinical and functional recovery) is commonly 
defined as the process of individual psychological adaptation to a disorder, contrasted with 
the reduction of psychiatric symptoms, relapse prevention or addressing functional 
difficulties (Cavelti, Kvrgic, Beck, Kossowsky, & Vauth, 2012). There is a clear focus on 
social justice in the recovery movement, and its implications for stigma, social inclusion and 
traditional health power structures are commonly discussed (Commonwealth of Australia, 
2013; Manove, Price, & Levy, 2012). “Personal recovery” is often abbreviated to “recovery”, 
and the shorter term is used here. 
This focus on recovery has been described as a humanistic paradigm shift in mental 
health (Wand, 2015), but the details of how recovery principles might operate in different 
mental health contexts have not been thoroughly considered to date (Murray, 2015b). 
Research into recovery in BD is in its early stages (see, e.g., S. Jones, L. D. Mulligan, S. 
Higginson, G. Dunn, & A. P. Morrison, 2013; S. Jones et al., 2012; Tse et al., 2014), and to 
our knowledge this is the first review to consider the implications of the recovery paradigm 
for psychosocial interventions for BD.  
Current evidence-based psychosocial interventions for BD include Cognitive 
Behavioural Therapy (CBT), Psychoeducation, Family-Focused Therapy (FFT) and 
















psychosocial treatments are broadly effective for BD maintenance therapy, and there is 
consensus that optimal management of BD involves integrated pharmacotherapy and 
psychotherapy (Goodwin, 2009; Yatham et al., 2013). On the other hand, data in the acute 
phase is limited, effect sizes for psychosocial interventions are not large, therapeutic 
mechanisms are poorly understood and more research is required to maximise their beneficial 
impact (Geddes & Miklowitz, 2013). Indeed, it is not clear that current research has targeted 
and measured critical outcomes, in taking a proto pharmacological stance rather than 
exploring what matters to service users. As there is no strong evidence of differential 
efficacy, treatment guidelines usually recommend offering any of the evidence-supported 
individual structured psychological interventions (e.g., Malhi et al., 2015; National Institute 
for Health and Clinical Excellence, 2014).  
Existing interventions for BD generally share a biopsychosocial diathesis-stress 
model, and a focus on development of knowledge and skills (Malhi et al., 2015). Evidence-
based interventions also have overlapping content: increased knowledge about BD, 
monitoring sleep and mood, enhanced ability to recognise and respond to mood changes, re-
engaging with social, familial and occupational roles, stress management, improved 
communication, medication adherence, enhanced sleep and activity rhythms and minimising 
substance use (Beynon, Soares-Weiser, Woolacott, Duffy, & Geddes, 2008). Critically for the 
present paper, then, the primary impetus of existing psychosocial interventions is to decrease 
symptoms and relapse: with some recent exceptions (e.g., S. H. Jones et al., 2015, see below), 
personal recovery has received little attention in the BD intervention literature.   
Measuring Outcomes of Psychosocial Interventions for Bipolar Disorder 
Commonly recognised elements of recovery are connectedness, hope and optimism, 
identity, meaning in life and empowerment (giving the acronym CHIME, (Leamy, Bird, Le 
















psychosocial interventions to be more congruent with these humanistic values (S. Jones et al., 
2013). Growing interest in recovery-congruent aims has, in turn, encouraged focus on 
outcome measures that capture broader subjective experiences of the individual. To date, 
QoL has received the most research attention (Murray & Michalak, 2012). 
The World Health Organization defines QoL as: “an individual’s perception of their 
position in life in the context of the culture and value systems in which they live and in 
relation to their goals, expectations, standards and concerns” (The WHOQOL Group, 1995). 
Importantly, QoL variables are not merely the inverse of symptom variables. That is, some 
patients maintain role functioning despite severe symptoms, while others report significant 
functional and QoL decrements in the context of relatively few symptoms. Indeed, QoL 
measures have only small to moderate negative correlations with symptom measures (e.g., E. 
E. Michalak & Murray, 2010). Trajectories of symptom and QoL outcomes also diverge over 
time, whether measured naturalistically (Morton et al., 2015) or in response to treatment 
(Ishak et al., 2011). Finally, patients see QoL and other foci that are broader than symptoms 
as core treatment targets (Sajatovic, Jenkins, Cassidy, & Muzina, 2009). 
The recovery perspective on mental health elevates QoL measurement, consistent 
with its prioritising of personal agency, context, meaning-making and lived experience (e.g., 
Commonwealth of Australia, 2013). QoL outcome measures emphasise individual experience 
across important life domains in the context of an individual’s culture and values system 
(Murray & Michalak, 2012).  
In sum, there is growing consensus that symptom measures alone do not capture 
clients’ or therapists’ aims and clinical outcome measures in BD should be augmented. 
Future investigations of recovery-focussed interventions may choose to prioritise measures of 
subjective QoL if these are in fact the primary aims of psychosocial treatment. Indeed, 
















‘psychoeducation’ (an intervention with a strong empowerment focus, see Stafford & Colom, 
2013) have employed QoL as the primary outcome (e.g., Poole, Simpson, & Smith, 2012). 
By being person- rather than symptom-focussed, QoL measures are also uniquely suited to 
measuring outcomes across the different stages of BD, as we consider below.  
Clinical Staging of Bipolar Disorder 
Stage-sensitive treatment approaches are common outside mental health. In cardiac 
health, for example, the ischaemic heart disease model contrasts at-risk individuals, those 
whose illness is showing signs of progression (symptoms of hypertension, metabolic 
syndrome etc.) and those with overt cardiac disease (e.g., angina, Hickie, Scott, & McGorry, 
2013).  
The staging approach is less well developed in psychiatry than other areas of 
medicine. In BD, the staging approach has overlap with the notion of neuroprogression, 
around which many empirical questions remain: A recent review concludes that 
neuroprogression is not a general rule in BD, but that a proportion of patients show this 
unfavourable course (Passos, Mwangi, Vieta, Berk, & Kapczinski, 2016). To avoid 
unwarranted demoralisation, then, it is important to stress to clients and clinicians that 
progression in BD is not universal and can potentially be reversed with optimal treatment and 
support.  
Staging models generate a number of testable predictions. First, earlier stages tend to 
have a better treatment response, a more favourable risk-benefit ratio and respond to more 
benign and potentially transdiagnostic therapeutic interventions. Second, if staging is 
aetiologically meaningful, earlier intervention should impact the course of the disorder. 
Third, to the extent that stage progression is underpinned by neurobiological changes, 
biomarkers should be discernible. Finally, and most critically for this review, treatments that 
















interventions due to their more personalised characterisation of the disorder (Berk, Hallam, & 
McGorry, 2007; Scott et al., 2013).  
The notion of BD staging is consistent with the recovery approach in prioritising 
interactions between person and disorder. In contrast to a narrow diagnosis-driven approach, 
stage tailoring aims to guide interventions according to the experiences and needs common to 
individuals at particular stages of their disorder. For example, individuals in the early stages 
of BD appear more likely to benefit from psychoeducation and traditional CBT (Scott et al., 
2013), while it has been suggested that acceptance-based interventions might be more 
beneficial in later stages (Berk et al., 2013). Indeed, there is some post hoc evidence that 
people in the later stages of BD may be harmed by existing psychosocial interventions (Scott, 
Paykel, Morriss, Bentall, Kinderman, Johnson, & Hayhurst, 2006). One mechanism of this 
apparent iatrogenic effect might be people’s unproductive self-appraisals when relapse 
prevention efforts prove ineffective.    
The Staging Model of BD 
Keeping in mind the important clinical caution that concepts of neuroprogression and 
staging can have negative implications that are not warranted by the data (above), there is 
growing interest in evidence for a progressive course in a (yet to be quantified) subset of 
patients with BD (Berk et al., 2011; Kapczinski et al., 2008; Post, Fleming, & Kapczinski, 
2012). Clinical data consistent with progression includes reducing duration of euthymia 
(normal mood) between episodes (Kessing & Andersen, 1999), declining treatment 
responsiveness with advancing stages (Ketter et al., 2006; Scott, Paykel, Morriss, Bentall, 
Kinderman, Johnson, Abbott, et al., 2006), increased rates of comorbidity (Matza, 
Rajagopalan, Thompson, & De Lissovoy, 2005), functional and cognitive impairment (Lin, 
Reniers, & Wood, 2013; Martinez-Aran et al., 2007; Rosa et al., 2012), and increased 
















consistent with evidence (in some samples) of progression in various biomarkers (see, e.g., 
Berk et al., 2011; Gama, Kunz, Magalhães, & Kapczinski, 2013; Kapczinski, Dias, et al., 
2009; Kapczinski, Fernandes, et al., 2009) in particular cognition and structural 
neuroanatomy (Blumberg et al., 2006; Soares et al., 2005). There is a dearth of prospective 
research into psychological and social factors in the toxicity of BD episodes, but a 
psychosocial kindling effect could be mediated through episodes’ impact on self-concept, 
stigma, hopefulness, social support, work function, appraisal mechanisms and other factors 
(Alloy et al., 2005; Weiss et al., 2015).  
Building on an influential generic staging model of serious mental illness by Fava and 
Kellner (Fava & Kellner, 1993), in turn expanded by McGorry and colleagues (McGorry, 
Hickie, Yung, Pantelis, & Jackson, 2006), Berk and colleagues have recently proposed a 
staging model specific to BD (Berk et al., 2013). The model encompasses five stages, 
beginning with Stage 0, an at-risk stage:  The rationale for including an at-risk stage comes 
from growing evidence for prevention of psychosis (Hutton & Taylor, 2013) and preliminary 
evidence that early administration of lithium or divalproex may be preventative in BD 
(Findling et al., 2007; Franchini, Zanardi, Smeraldi, & Gasperini, 1999).  
Stage 1 of the BD staging model refers to the presence of mild and often non-specific 
symptoms (e.g., anxiety and sleep symptoms, rumination, unstable self-esteem)(Duffy, Jones, 
Goodday, & Bentall, 2016) which may progress to prodromal patterns. Potential interventions 
at this stage include formal psychological or pharmacological therapy. Stage 2 reflects a first 
criterion episode of BD (i.e., a hypomanic or manic episode). Potential interventions at this 
stage include formal psychological and pharmacological therapy as well as case management 
and vocational rehabilitation. While some people only experience a single episode, many 
progress to Stage 3, a pattern of remission and recurrence and more chronic sub-syndromal 
















mood stabilisers and an emphasis on treatment adherence and psychosocial therapy aimed at 
full remission, or relapse prevention. Finally, some people may progress to Stage 4, an 
unremitting or treatment refractory course; potential interventions include all of the previous 
treatments plus clozapine and other tertiary therapies and encouragement of social 
participation despite disability. Alternate staging models of BD follow a similar structure but 
highlight other stage distinguishing criteria, e.g., functioning and biomarkers (Kapczinski, 
Dias, et al., 2009).  
Support for the staging model of BD comes from various sources (see reviews by, 
Berk et al., 2013; Vieta, Reinares, & Rosa, 2011). Using the data from STEP-BD, for 
example, Magalhaes and colleagues found that BD stage (operationalised in number of 
previous episodes), was a prognostic indicator for cross-sectional and prospective outcomes 
(Magalhaes, Dodd, Nierenberg, & Berk, 2012). Rosa and colleagues found support for the 
staging model in one-year functional outcomes following an episode of BD: outcomes were 
significantly better after the first, as opposed to latter episodes (Rosa et al., 2012).  
In the absence of large-scale prospective studies, many questions remain about 
disorder progression and staging in BD. Important caveats include the relationship between 
progression and related notions like phenotypic severity, age of onset, and developmental 
stage (Berk et al., 2013). Stage of disorder is also not the only individual difference variable 
that could potentially improve the targetting of psychosocial interventions for BD (see`for 
example Kriegshauser et al., 2010; Popovic et al., 2013). Nonetheless, there are compelling 
grounds for investigating the hypothesis that outcomes (particularly recovery-relevant 
outcomes like QoL and meaning in life) are improved by tailoring to stage of disorder 
(Reinares et al., 2013; Scott et al., 2013). The recovery movement emerged from consumers 
with chronic mental health conditions, making the argument that the ultimate goal of 
















symptom mitigation: This call becomes more important as symptoms may become potentially 
less responsive to treatment after multiple episodes, and pathways to QoL may thus diverge.  
Towards Staged Psychosocial Interventions 
The staging framework suggests that intervention may be more effective and benign 
when provided at early stages, and it has been argued that early intervention in BD may 
circumvent the accumulation of associative processes that increase vulnerability with each 
episode (e.g., S H Jones, 2001). Existing psychotherapies primarily target people in the mid-
stages of BD (i.e., a small number of discrete episodes or Stage 3):  One way in which 
therapeutic power may be enhanced is through stage-tailoring.  
Research into the effect of psychotherapy for prevention (Stage 0) and early 
intervention (Stage 1) is emerging. Nadkarni and Fristad (2010) conducted a large scale 
randomised controlled trial (RCT), finding that family psychotherapy and psychoeducation 
significantly reduced conversion rates from depressive and manic symptoms to full-blown 
BD in children. Other studies found symptom and functioning improvements, especially in 
depressive symptomatology (see Vallarino et al., 2015). Two large scale RCT’s are currently 
underway. Miklowitz and colleagues are examining the efficacy of psychosocial treatment of 
individuals at high risk of developing BD (D. J. Miklowitz et al., 2013). Inclusion criteria are 
a “vulnerable diagnosis” (cyclothymia, major depressive disorder or BD not otherwise 
specified [NOS]), plus a familial history of BD I or BD II and active mood symptoms. 
Pfennig et al. (2014) are examining the efficacy of early CBT in individuals who have a 
family history of affective or schizoaffective disorder and have had reduced functioning in 
the preceding 12 months and have some subthreshold affective symptomology. 
Further, Jones and colleagues (S. H. Jones et al., 2015) have recently completed a 
pilot RCT of recovery-focussed CBT for people with early stage BD (Stage 2, with diagnosis 
















Jones, L. D. Mulligan, S. Higginson, G. Dunn, & A. P. Morrison, 2013), QoL and relapse 
rates. Likewise, Macneil and colleagues have developed an intervention for Stage 2 (first 
episode) BD, and have pilot data suggesting efficacy for depressive symptoms and functional 
outcomes (Macneil et al., 2011).  
Stages 0 and 1 of BD are characterised primarily by familial risk and non-specific 
vulnerability symptoms, which are also risk factors for anxiety disorders, unipolar depression 
and schizophrenia (Hunt, Schwarz, Nye, & Frazier, 2016; Vallarino et al., 2015). As argued 
recently by Scott et al, it may be that less specific transdiagnostic interventions are most 
effective at these early stages (Scott et al., 2013). Early interventions for BD may therefore 
not require strong face validity qua interventions for BD:  Indeed, to increase engagement 
and minimise stigma, early interventions may eschew content relevant to mid-stage BD and 
adopt an approach more suited to the person’s developmental stage (for related considerations 
in psychosis, see McGorry, Killackey, & Yung, 2008). Measures of QoL may therefore be 
particularly important for assessing psychosocial intervention outcomes in the early stages of 
BD, as they, a) are not restricted to the symptoms that define the full-blown disorder, and b) 
provide a more positive, strengths-focused target for intervention. The growing body of work 
on transdiagnostic approaches to psychotherapy (Barlow et al., 2010; T. A. Brown & Barlow, 
2009; A G Harvey, Watkins, Mansell, & Shafran, 2004) aligns with the proposal that 
diagnostic specificity has been overstated as a value for psychosocial treatments (Carl, 
Soskin, Kerns, & Barlow, 2013; A. G. Harvey, Murray, Chandler, & Soehner, 2011), and 
preliminary work by Barlow’s group shows that the transdiagnostic approach is useful in BD 
(Ellard, Deckersbach, Sylvia, Nierenberg, & Barlow, 2012).  
At the other end of the staging spectrum, little empirical attention has been paid to the 
late stages of BD, where the staging approach may have significant potential (Scott et al., 
















group has not been adequately addressed: Medication advice tends to be poorly supported by 
evidence, and little attention has been paid to tailoring psychosocial approaches. 
Consequently, the significant proportion of people who do not respond to existing treatments 
for BD are at risk for a greater burden of side-effects, and increased stigma. In such cases, the 
symptom-focussed models of routine clinical practice may be less effective than approaches 
that recognise the unavoidability of suffering, and emphasise redefinition of life goals (Berk 
et al., 2012). In the late stage group, then, interventions prioritising QoL or recovery 
outcomes may have particular relevance. The mindfulness-based or ‘third wave’ psychosocial 
interventions that have risen to prominence over the past decade are particularly interesting in 
this context.  
Mindfulness-Based Therapies for Bipolar Disorder 
The concept of mindfulness has been taught in Buddhist philosophy for centuries and 
applied in western health contexts since the 1970s (e.g., Kabat-Zinn, 1982). More recently, it 
has been included in formal psychological therapies (for reviews, see Chiesa & Serretti, 
2011; Hayes, 2004; Keng, Smoski, & Robins, 2011; Phang & Oei, 2012). Mindfulness as 
applied in psychological therapies has two defining features, namely, deliberate awareness of 
experiences in the present moment and a non-judgemental, accepting orientation towards 
these experiences (Kabat-Zinn, 1994, 2003).  
Mindfulness-based interventions (MBIs) therefore align with the recovery perspective 
through their emphasis on subjectivity and experiential awareness, as well as the deliberate 
acceptance of experiences as a means to leading a satisfying life within the limitations of 
serious mental disorder. These characteristics are shared by Mindfulness-Based Stress 
Reduction (MBSR; Kabat-Zinn, 1982), Mindfulness-Based Cognitive Therapy (MBCT; 
Segal, Williams, & Teasdale, 2002), Dialectical Behaviour Therapy (DBT; Linehan, 1993), 
















Therapy (ACT; Hayes, Strosahl, & Wilson, 1999). These therapies are characterised as ‘third 
wave’ in the sense that they arise from a clinical/scientific tradition commencing with 
behavioural approaches in the 1960s and 1907s, and progressing through cognitivist 
approaches in the late 20
th
 C (Herbert & Forman, 2011).  
MBIs differ from traditional psychological therapies such as Cognitive Therapy (CT) 
in several ways. For example, both CT and MBCT encourage viewing thoughts as mental 
events rather than facts and recognise the role of negative thoughts in maintaining distress 
(Barnhofer, Crane, & Didonna, 2009). However, while CT focuses on changing the content 
of negative thoughts and developing alternative cognitions via evaluation and the 
development of cognitive coping skills (Blagys & Hilsenroth, 2002; Teasdale, Segal, & 
Williams, 1995), MBCT aims to loosen the relationship between negative thoughts and 
distressing emotions via awareness and acceptance (Greco & Hayes, 2008). Relatedly, the 
former emphasises “doing” (e.g., mood monitoring, rhythm adjustment, communication and 
problem-solving etc.) to manage mood while MBIs emphasise “being” with both pleasant and 
unpleasant experiences (Deckersbach, Hozel, Eisner, & Lazar, 2014). Further, following 
Beck’s influential work, CT is usually based on disorder-specific models (e.g., CT for bipolar 
disorder), while MBIs are generally transdiagnostic in the sense that they enhance 
transdiagnostic processes including awareness, metacognition, acceptance, attentional 
control, memory, values clarification and behavioural self-regulation (Keng et al., 2011). 
Finally, mindfulness-based approaches are in a sense ‘non-diagnostic’ and presumed to 
impact both psychopathology and psychological wellbeing, thus a common feature of MBIs 
is that clinicians are encouraged to adopt the practice themselves (see Hayes, Villatte, Levin, 
& Hildebrandt, 2011). 
There is significant variety amongst the MBIs. For example, while MBCT and MBSR 
















and DBT integrate the principles of mindfulness with broader therapeutic methods. ACT has 
an explicit focus on reducing the maladaptive impact of cognitive and emotional experience 
on day-to-day behaviour. In ACT, mindfulness is used in conjunction with experiential 
exercises and metaphors to assist clients to observe bodily sensations, thoughts and emotions 
without reacting to them habitually (e.g., with avoidance, impulsivity or striving for social 
approval). This is proposed to increase psychological flexibility and enable attention and 
resources to be directed towards behaviours that serve valued life goals (Hayes, 1994; Hayes 
et al., 1999). The core of CFT is “compassionate mind training”, which utilizes mindfulness 
to enhance attributes of compassion such as understanding, accepting and feeling compassion 
for the self (Gilbert, 2009). DBT utilises skill-training and exposure therapy to enhance self-
acceptance and reduce avoidance of emotionally challenging situations (Linehan, 1993). 
Although the quality of the evidence remains low (see e.g., Churchill et al., 2013; 
Hunot et al., 2013), a growing literature suggests that MBIs may be useful across a range of 
disorders. Trials suggest that MBSR, for example, improves physical and psychological 
symptoms in various clinical and non-clinical disorders (see Grossman, Niemann, Schmidt, & 
Walach, 2004; Keng et al., 2011). MBCT has been shown to reduce depressive relapse for 
those with a history of at least 3 episodes of recurrent depression (Piet & Hougaard, 2011), 
and improves residual depressive symptoms in people diagnosed with major depression (see 
Chiesa & Serretti, 2011; Keng et al., 2011), although consistent effects have not been shown 
among those with less than three episodes of depression. DBT is effective in reducing various 
symptoms in clinical samples (see Keng et al., 2011; Lynch, Chapman, Rosenthal, Kuo, & 
Linehan, 2006), initial empirical studies of CFT have demonstrated symptomatic 
improvement especially in mood disorders (see Leaviss & Uttley, 2015), and ACT is 
















Powers, Zum Vörde Sive Vörding, & Emmelkamp, 2009; Swain, Hancock, Hainsworth, & 
Bowman, 2013).  
Importantly for this review, a range of studies have demonstrated that MBIs may be 
efficacious for severe mental disorders, including schizophrenia (Davis & Kurzban, 2012; 
Khoury, Lecomte, Gaudiano, & Paquin, 2013). Indeed, Davis and Kurzban (2012) argue that 
since severe mental illness is typically associated with persistent and debilitating 
psychosocial stressors, and MBIs enhance coping and reduce stress, that “mindfulness-based 
interventions may be uniquely suited to impact distress related to symptoms and internalized 
stigma that are particularly salient for individuals living in the community with severe mental 
illness who are susceptible to experiences of social rejection and interpersonal stress” (pp. 
227-228).  
A number of clinical trials have shown that ACT reduces hospitalisation rates, 
believability of symptoms, affect severity, symptom distress and social functioning of 
inpatients with psychotic mood disorders (e.g., Bach & Hayes, 2002). Furthermore, 
mindfulness training has been shown to improve wellbeing, insight, coping, self-efficacy and 
clinical functioning and also to reduce aggression, stress, negative and positive symptoms and 
anxiety in people diagnosed with schizophrenia (Abba, Chadwick, & Stevenson, 2008; L. F. 
Brown, Davis, Larocco, & Strasburger, 2010; Chadwick, Hughes, Russell, Russell, & 
Dagnan, 2009; Chadwick, Taylor, & Abba, 2005; Chien & Lee, 2013; Dannahy et al., 2011; 
Davis, Strasburger, & Brown, 2007; Langer, Cangas, Salcedo, & Fuentes, 2012; Shawyer et 
al., 2012; Singh et al., 2007; Van der Valk, Van de Waerdt, Meijer, Van den Hout, & De 
Haan, 2013; White et al., 2011). 
To date, most RCTs have compared MBIs with treatment-as-usual (TAU) or wait-
listed controls. The small group of studies comparing mindfulness-based approaches with 
















Yeomans, & Geller, 2007; Lappalainen et al., 2007; Linehan et al., 2002; Manicavasgar, 
Parker, & Perich, 2011; Piet, Hougaard, Hecksher, & Rosenberg, 2010; Powers et al., 2009; 
Turner, 2000; Zettle & Rains, 1989), and larger, better-controlled studies are required before 
definitive conclusions can be drawn about the relative strength of MBIs across the range of 
psychopathologies.  
There are strong grounds for hypothesising that MBIs may be particularly useful for 
BD, irrespective of stage. In a highly-cited review, Holzel et al. (2011) consider 
psychological and neurobiological evidence for five mechanisms implicated in the 
therapeutic benefits of mindfulness:  attention regulation, body awareness, emotion regulation 
(reappraisal and exposure/extinction/reconsolidation) and change in self-perspective. As 
summarised in Table 1 below  (adapted from Holzel et al., 2011), alterations in at least some 
of these pathways could, a) redress vulnerabilities to the core symptoms of BD, b)  be 
effective in addressing common comorbidities in BD, and c) improve psychosocial 
functioning and quality of life in BD. It has been recently noted that two further areas of 
deficit in BD - emotional reactivity and cognitive function – may also respond to MBI 
(Deckersbach et al., 2014). 
 
INSERT TABLE 1 ABOUT HERE 
 
Outcomes of Mindfulness-Based Therapies for Bipolar Disorder 
To date, clinical trials examining the efficacy of MBIs in BD have typically ignored 
stage of disorder. Risk of bias remains high in the existing literature, which is characterised 
by small samples, often open trials, and studies with weak controls (see Table 2).  
 
















The majority of studies have investigated MBCT with findings generally, but not 
uniformly, positive. Preliminary evidence suggests that MBCT can reduce symptoms of 
anxiety, mania and depression and suicidal ideation (e.g., D. Miklowitz et al., 2009; Williams 
et al., 2008) and improve mindfulness, emotion regulation, psychological well-being, positive 
affect, psychosocial functioning and cognitive function in BD (e.g., Deckersbach, Hölzel, et 
al., 2012; Howells, Ives-Deliperi, Horn, & Stein, 2012; Ives-Deliperi, Howells, Stein, 
Meintjes, & Horn, 2013; Stange et al., 2011). In contrast, a small feasibility study by Weber 
and colleagues found no changes in depressive symptoms with MBCT (2010). A pilot 
investigation of a DBT-based psychoeducational group found decreased emergency room 
visits and admissions in the 6 months post group treatment, but no treatment effects on 
depressive symptoms (Van Dijk, Jeffrey, & Katz, 2013). A qualitative study conducted by 
Chadwick, Kaur, Swelam, Ross and Ellett (2011) found that people with BD who practiced 
mindfulness for at least 18 weeks had improved awareness of their mood and were more able 
to focus on the present, stabilise negative affect, relate differently to negative thoughts and 
reduce the impact of their current mood state. Interestingly, two studies have found 
neurocognitive and brain function improvements to occur alongside MBCT-induced clinical 
change in BD (Chiesa, Serretti, & Jakobsen, 2013; Howells et al., 2012; Ives-Deliperi et al., 
2013): These early studies suggest that mindfulness has benefits for the neurobiology of 
emotion regulation, a well-documented challenge in BD (see Townsend & Altshuler, 2012). 
The largest RCT examining the efficacy of a MBI in BD (N = 95) (Perich, 
Manicavasagar, Mitchell, Ball, & Hadzi-Pavlovic, 2013) found no differences between TAU 
and TAU + MBCT on either time to first relapse or total number of relapses over 12 months’ 
follow-up. The groups also did not differ on measures of depressive or manic 
symptomatology. Consistent with less rigorous studies, however, the experimental group 
















functioning were not measured in the Perich et al study. Likewise, in the negative study of 
Weber et al. (2010) mentioned above, participants reported subjective benefits of the program 
that were not captured in the clinical outcome measures employed. Consistent with their dual 
focus on psychopathology and mental health, MBIs have consistently been shown to impact a 
range of measures that fall under the umbrella of wellbeing (anxiety, attention, psychosocial 
function, emotion regulation, positive affect, mindfulness, etc.) and may be well captured in 
QoL, recovery and functioning measures.  
Are Mindfulness Based Therapies Relevant to Early Stages of BD? 
At the early stages of BD, pathology appears in non-specific symptoms including 
anxiety, depression, substance use and sleep problems (De Almeida, Nery, Moreno, 
Gorenstein, & Lafer, 2011; Heissler, Kanske, Schonfelder, & Wessa, 2014; Jylhä et al., 2010; 
Lombardo et al., 2012; Olsavsky et al., 2012). The MBI focus on awareness may be 
especially applicable in these early stages because they have been shown to improve 
symptoms of negative affect, impulsivity, and sleep disturbance (Hölzel et al., 2011; 
Hülsheger, Alberts, Feinholdt, & Lang, 2013; Ortner, Kilner, & Zelazo, 2007; Smith et al., 
2008; Soler et al., 2012).  
Impulsive reactivity to intense emotions, particularly positive emotions (which may 
accelerate risk taking and overactivity) has been identified as a problem for people with BD, 
even between episodes (Muhtadie, Johnson, Carver, Gotlib, & Ketter, 2013). Core to 
mindfulness-based therapies is training to stand back, observe and accept emotions and 
thoughts rather than respond reactively (Keng et al., 2011). Learning such skills in the early 
stages of BD could potentially enhance the capacity to deal more effectively with strong 
emotions, decrease rumination and implement emotion-dystonic self-management and social 
rhythm maintenance strategies (e.g., getting out of bed when depressed, avoiding stimulation 
















Furthermore, mindfulness-based promotion of psychological wellbeing in the early 
stages of BD may be an important factor in preventing progression (Bolge, Thompson, 
Bourne, & Nanry, 2008). A number of studies have reported a relationship between trait 
mindfulness and psychological wellbeing in both non-clinical (e.g., Baer, Smith, Hopkins, 
Krietemeyer, & Toney, 2006; K. W. Brown & Ryan, 2003) and clinical populations (e.g., 
Baer, Smith, & Allen, 2004; Walach, Buchheld, Buttenmüller, Kleinknecht, & Schmidt, 
2006) as well as causal relationships between mindfulness meditation and psychological 
wellbeing (Carmody & Baer, 2008; Huppert & Johnson, 2010; W. K. Lee & Bang, 2010; 
Nyklíček & Kuijpers, 2008). Transdiagnostic mindfulness-based therapies in the early stages 
of BD may therefore help people to distance themselves from symptoms at this particularly 
delicate developmental time. As argued above, QoL outcome measures may provide the most 
valid assessment of the effectiveness of interventions for this early stage group (characterised 
by non-specific symptoms and at high risk of self-stigma).  
Are Mindfulness-Based Therapies Relevant to Late-Stage BD? 
There is also reason to propose that mindfulness-based therapies have potential utility 
for late-stage, persistent, chronic, or treatment resistant BD (Stage 4). Mindfulness has been 
found to moderate the relationship between unavoidable distressing experiences and mental 
health outcomes (Bergomi, Ströhle, Michalak, Funke, & Berking, 2013), and it seems 
plausible that MBIs may also help people with BD carry an ongoing risk of symptoms and 
relapse. Deckersbach et al. (2014) suggest that MBIs may be particularly effective for late 
stage BD since rumination about negative and positive events is a key residual symptom 
during this stage. They note that mindfulness aims to help individuals treat thoughts and 
feelings as mental events rather than reflections of reality, thus reducing negative and positive 
















Acceptance of extreme mood states (contrasted with experiential avoidance), and 
commitment to behaviours in line with life-enriching personal values despite symptoms 
appears particularly relevant for late stage BD. Acceptance is a goal of most third wave 
therapies, and particularly elevated in ACT (Herbert & Forman, 2011). Indeed, the ACT 
premise that suffering is an unavoidable part of life (Hayes et al., 1999) has the potential to 
reassure and empower a population whose disorder has proven difficult to manage (Berk et 
al., 2012). In ACT, acceptance of distress is addressed through various metaphors and 
exercises. The quicksand metaphor, for example, points out that struggling against quicksand 
leads us to sink further, while being in full contact with the quicksand (by leaning back into 
the sand) keeps us afloat (Hayes & Smith, 2005). 
The third wave therapeutic notion of acceptance of difficult experiences is therefore 
congruent with the personal recovery focus on maximising QoL despite ongoing symptoms 
(Berk et al., 2012). One of the four ‘noble truths’ of Buddhism is dukkha, usually translated 
as ‘Life is suffering’: For people carrying a chronic severe form of BD, the notion that 
suffering connects rather than isolates us from others is likely to be therapeutic. In practice, 
promoting an experience of self as observer of difficult experiences, and letting go of self-
evaluation, may facilitate adaptation to threats that arise from impaired functioning and 
stigmatising life-events.  
Consistent with this reasoning, a number of studies have found ACT to be efficacious 
for treatment resistant (e.g., Clarke, Kingston, Wilson, Bolderston, & Remington, 2012; 
Markanday et al., 2012) and chronically mentally ill individuals (e.g., Bach & Hayes, 2002; 
Bach, Hayes, & Gallop, 2012). Cross-therapy features of mindfulness, particularly mindful 
acceptance of internal experiences, and potential remediation of attention deficits (see Table 
















Our group recently published positive findings from an open trial of an online MBI 
for late stage BD (Murray et al., 2015, see Table 1). Consistent with arguments above, the 
primary target of this intervention is QoL, and content focuses on BD-specific learnings 
around the use of mindfulness, developing and acting on values, and self-compassion in the 
context of a chronic and disruptive disorder. The intervention is currently undergoing 
refinement and definitive international RCT.  Likewise, Tyler and colleagues are currently 
undertaking a feasibility trial of recovery-focused CBT amongst older adults with BD (Tyler 
et al., 2016).    
Discussion 
The sea-change towards recovery-oriented services in mental health points to a 
corresponding need for a change in direction for BD practice and research. Arguably, practice 
has outpaced research in this domain, and researchers must catch up to a paradigm that is 
already extremely popular in public mental health (Tse et al., 2014). Our preceding review 
suggests that QoL will be a growing focus of interventions for BD within recovery-oriented 
practice and research, recently articulated models encourage greater tailoring of interventions 
to better capture the meaning of diagnosis for people at different stages of BD, and MBIs 
warrant further investigation across the stages of BD. The strengths and weaknesses of these 
propositions are addressed, before we consider next steps for research into recovery-oriented 
psychosocial interventions for BD.  
QoL as an Outcome Variable in BD Research and Practice 
Person-centric treatment goals are central to the recovery paradigm. Mental health 
services for people with persisting mental health problems like BD now prioritise personal 
recovery, viz., a focus on living a rewarding life despite ongoing resistant symptoms and 
intermittent episode recurrence. The outcome variable receiving most scientific attention in 
















treatment goal (S. H. Jones et al., 2013; National Institute for Health and Clinical Excellence, 
2014).   
Growing consumer interest in QoL as a treatment goal has been paralleled by rigorous 
methodological work on measurement of QoL in BD (Murray & Michalak, 2012). In 2010, 
Michalak and Murray published the first disorder-specific measure of QoL in BD (the 
QoL.BD), based on a 5-year multi-method program of research (E. E. Michalak & Murray, 
2010). The QoL.BD has now been translated into 19 languages, is currently an outcome 
measure in 16 large-scale clinical studies, and a multi-national epidemiological study of BD 
phenomenology. Disorder-specific QoL measures are significantly more sensitive to 
treatment-related change than generic instruments, because, when appropriately developed in 
close consultation with the population of interest, they are more likely to capture key 
concerns and characteristics of the population (Wiebe, Guyatt, Weaver, Matijevic, & Sidwell, 
2003). We have consequently argued that, alongside traditional clinical endpoints, outcomes 
in BD clinical trials should include well-validated measures of subjective QoL (Murray & 
Michalak, 2012). Measurement of QoL can also play an important clinical role in 
psychosocial treatment, by identifying treatment aims that are positively motivating for the 
client, potentially maximising treatment adherence (Hope, Page, & Hooke, 2009).  
Questions also remain about the relationship between QoL measures and emerging 
measures explicitly focusing on the recovery concept itself. While QoL measures assess 
satisfaction in various domains at a point in time, recovery is often characterised as a 
teleological process of ongoing efforts to maximise autonomy and meaning in the context of 
disorder. While qualitative methods are commonly used to examine recovery as a process 
(e.g., Dunn, Wewiorski, & Rogers, 2008; Mansell, Powell, Pedley, Thomas, & Jones, 2010), 
Jones and colleagues have recently published a self-report measure of recovery in BD, the 
















outcome measure for recovery-oriented interventions. Correlations between the BRQ and 
QoL measures are in the order of .5 - .6 (Jones, personal communication, May, 2016), 
suggesting the variables are associated but not mutually redundant.  
It is important to note one caveat on this optimism about QoL measurement in BD. 
The literature on QoL in BD is only nascent, compared to longstanding research into QoL in 
schizophrenia - in that field, it has been argued that the study of QoL has failed to produce 
expected real-word impact (Awad & Voruganti, 2012). Awad and Voruganti (2012) argue 
that lack of clarity around conceptual issues, difficulty combining data across multiple 
measures, ongoing questions about the impact of psychopathology on QoL, and lack of 
research regarding clinical applications of QoL data has led to a lack of impact on clinical 
care, clinical trials, and allocation of healthcare resources. To ensure that QoL in BD does not 
also become an ‘unfulfilled promise’, future research should aim to address measurement 
ambiguities, investigate the dynamics of QoL in relation to symptom change in various BD 
populations, explore the lived experience of people with BD working to improve their QoL, 
and investigate ways of maximising the impact of QoL theory in clinical and self-care 
settings.  In the interim, it will be important for naturalistic and treatment studies to select 
QoL instruments carefully (Morton, Michalak & Murray, In Press), and to supplement with 
secondary symptom measures where relevant.   
Staging to Improve Intervention Tailoring for BD 
Much remains unknown about the staging approach to BD and related notions 
including neuroprogression, kindling and allostatic load (Kapczinski et al., 2008; Weiss et al., 
2015). Key empirical questions include the optimal criteria for defining the stages of BD 
(number of episodes, current functioning, response to treatment, etc.), the percentage of 
people diagnosed with Stage 2 BD who progress to Stage 3 and then Stage 4, and 
















issue is whether early intervention can change the course of BD progression, particularly 
given early promising evidence on this front. Urgent attention to these fundamental questions 
will help assess the validity of the staging notion in BD, and hence its importance as a 
component of the individualised treatment approach encouraged by the recovery framework.  
Although the staging concept warrants further investigation in BD, we have noted that 
the term ‘staging’ itself has fatalistic connotations. Common associations with other staged 
conditions (e.g., palliative care for end stage cancer) are both unwarranted and dispiriting for 
people with BD. Staging in BD is not inevitably linear and irreversible. Rather, staging is one 
of the tools that may help optimise and tailor BD treatment to the more specific needs of the 
individual at a particular point in time. Especially in a recovery context, we offer the 
alternative term, ‘experience with BD’ (ranging from limited to substantial) for future 
researchers to consider. Experience with BD refers to measureable history of BD (e.g., 
number of prior episodes, pervasiveness of current challenges), but avoids negative 
prognostic connotations of the current terminology.   
The present paper has emphasised stage (indexed, for example in number of prior 
episodes) as a moderator of outcome, and consequently as a framework to create meaningful 
BD subpopulations for treatment development. However, staging is not the only way to 
effectively tailor psychosocial interventions for BD. Indeed, interventions based on 
individually-tailored, case-formulation-based application of content elements from the 
evidence-based treatments are emerging (S. H. Jones et al., 2015; Macneil, Hasty, Conus, & 
Berk, 2012). The recovery framework encourages clinical attention to the unique individual 
and their preferences - we hypothesise that ‘stage’ (or better, ‘experience with BD’) 
constitutes one potentially important parameter of such a personalised medicine for BD.   
Berk et al (2012) warn of evidence that standard symptom-focussed psychosocial 
















Bentall, Kinderman, Johnson, & Hayhurst, 2006). Compromised neurocognition, damaged 
self-esteem, heightened self-stigma and diminished motivation might underpin a negative 
experience of CBT in the late stages of BD. Indeed, the relapse-prevention focus of existing 
psychosocial interventions (see above) may be demoralising in a population with limited 
agency over their disorder. Instead, interventions encouraging constructive acceptance of this 
undesirable reality (‘the unwanted guest’) and focusing on defining and acting on personally 
meaningful values may be superior. Moreover, paradox can be an active psychotherapeutic 
ingredient, and eschewing symptomatic improvement as a target may lead to its inadvertent 
improvement (Palazzoli & Boscolo, 1994).  
Mindfulness-Based Interventions  
Existing research into MBIs for BD is encouraging, but characterised by poor quality 
evidence and therefore far from definitive (the evidentiary base for currently recommended 
psychosocial interventions for BD is also moderate at best, Oud et al., 2016). A number of 
smaller studies have shown consistent effects of MBCT on both the symptoms of BD and on 
broader wellbeing outcomes. However, the largest RCT to date was negative against its 
primary clinical outcome measures. Clinical trials (of varying rigour, mainly testing MBSR) 
targeting the traits and features relevant to early stage BD suggest that mindfulness 
approaches may be effective at this early intervention stage. Similarly, studies of people with 
serious mental illness have found mindfulness to be effective (particularly in ACT form), 
suggesting the potential of mindfulness-based approaches for late stage BD. It is reasonable 
to conclude that investigation of the potential benefit of stage-sensitive, mindfulness-based 
therapies for BD is warranted.   
It is nonetheless important to remain sceptical about MBIs. First, when viewed at the 
micro-level of clinical process, it may be that differences between acceptance/mindfulness 
















Relatedly, direct tests of mindfulness-based approaches versus traditional psychotherapies are 
in their infancy and findings to date do not support MBIs over more established therapies 
(Hunot et al., 2013).  In BD, an important empirical question is whether MBIs are 
preferentially effective for depressive over hypo/manic symptoms: racing thoughts and 
increased activation are likely a greater barrier to present-moment awareness (and its 
therapeutic benefits) than are slowed thoughts and decreased activation.  Relatedly, 
behavioural strategies may be superior for managing this pole. Trials designed to parse the 
relative strengths and weaknesses of the two overlapping approaches (e.g., via direct 
comparison of psychoeducation versus mindfulness-based therapies’ impacts on depression, 
mania and QoL outcomes) are urgently required. Most importantly, there may be some risks 
associated with offering MBIs to people with BD as we consider next.  
The ontology of Buddhism is distinctly non-Western (see Murray, 2015a; Olendzki, 
2010), and so mindfulness training could potentially be destabilising for people with BD. In 
particular, it is important to consider whether mindfulness practices may exacerbate 
grandiose and spiritual thinking in hypo/manic states. Data from the largest trial to date do 
not support a link between mindfulness meditation practice and mania (Perich, 
Manicavasagar, Mitchell, & Ball, 2013), and qualitative reports suggest that clients choose 
not to meditate in highly aroused or depressed states (Chadwick et al., 2011).  Emerging 
evidence for the safety of MBIs - when appropriately adapted - for psychosis (Chadwick, 
2014) also provides some reassurance.  Nonetheless, future research should directly test this 
hypothetical iatrogenic pathway.  In the interim, MBIs for BD should be tailored for BD, and 
include psychoeducation about the potential risks of mindfulness in managing emergent 
elevated mood (Deckersbach et al., 2014).  
At first glance, the MBI emphasis on ‘acceptance’ of extreme mood states could be 
















fact, the twin processes of acceptance and problem-solving occur across different time 
frames: mindful acceptance of extreme experiences in the moment accords with concerted 
efforts to decrease serious episodes of illness where possible (Hayes et al., 2011).  By being 
non-judgementally aware of an elevated mood state, for example, a person with BD might 
choose to eschew further stimulation out of commitment to the valued goal of minimising 
BD’s impact on their family.  Indeed, mindfulness is described by people with BD as being 
an effective part of relapse prevention strategies (Chadwick et al., 2011).  
Future research 
Studies reviewed here provide some initial clues about which elements of third wave 
therapies may be beneficial across the stages of BD.  The transdiagnostic approach of MBSR 
and ACT may be particularly well suited to Stages 0 and 1 of BD, in which symptoms are 
non-specific, and a focus on symptoms of disorder may be unnecessarily stigmatising and 
demotivating. Unlike MBCT and MBSR, ACT does not require people to develop a 
mindfulness meditation practice, and thus may be less impacted by amotivation in late stages, 
and ambivalent motivation in middle stages of BD (Lau & McMain, 2005). Indeed, ACT is 
largely based on experiential learning (leveraging off metaphors and exercises) and may be 
more engaging for a population characterised by creativity (S L Johnson et al., 2012; Murray 
& Johnson, 2010). Furthermore, ACT’s emphasis on action being driven by explicit, valued 
goals instead of evaluative stories about who the person is (Hayes et al., 1999; Veiga-
Martínez, Pérez-Álvarez, & García-Montes, 2008) may mitigate achievement striving in BD 
(e.g., Johnson, Fulford, & Carver, 2012; R. Lee, Lam, Mansell, & Farmer, 2010). As argued 
above, further research should consider adding QoL outcome measures to capture the broad 
impact of these trans- and non-diagnostic interventions.   
















The intent of the present project was to identify well-grounded pathways for future 
research/practice in recovery-oriented psychosocial management of BD. A limitation of the 
project was the dearth of good-quality data to support conclusions for current evidence-based 
practice (Oud et al., 2016). For example, little remains known about optimising subjective 
QoL in BD, with no completed RCTs to date. We hope that the present review will encourage 
broader research activity, which will in turn support a future more systematic empirical 
review of the three topics introduced here.  
As we have noted elsewhere, a challenge for forwarding empirical research into 
recovery in BD is the complexity of the recovery construct itself (Leitan, Michalak, Berk, 
Berk, & Murray, 2015). In particular, the necessary and sufficient features of a ‘recovery-
oriented intervention’ are difficult to define. One intervention could be considered recovery-
oriented in aiming to build hope and connectedness through training in relapse prevention; 
another intervention may eschew symptom management altogether and be structured around 
individualised QoL goals.   
Finally, while the present project focused on psychosocial intervention, the recovery 
paradigm invites questions about the role of the person with BD in medication decisions, 
hospitalisation, involuntary treatment, etc. (Wand, 2015). Worldwide, there are increasing 
calls from consumers to be more actively involved in their own treatment decisions as part of 
recovery-oriented care. Tse et al explored some of these issues in one of the first recovery-
oriented publications in the BD field (Tse et al., 2014), finding evidence for a number of 
resilience-engendering features of health services, prominently including respect, hope and 
self-directed empowerment. These issues are complex, however, and we have warned that the 
recovery emphasis on self-management is not a justification for decreased professional 
involvement in mental health, but is a stimulus for more intelligent support and resourcing 
















research to ensure the humanistic recovery perspective is implemented effectively and 
efficiently.  
Conclusions 
While existing psychosocial treatments for BD warrant further refinement (David J. 
Miklowitz & Scott, 2009),  the present review sought to encourage research into new 
approaches which align in various ways with the humanistic ‘recovery’ concept.  The 
constructs of QoL, mindfulness and staging are not new in clinical psychology, but they have 
received limited attention in relation to serious mental disorders like BD.  Evidence reviewed 
here suggests that the construct of QoL has face validity, and a growing empirical base to 
support its use as a key person-centric treatment goal in BD.  Stage (or ‘experience with BD’) 
appears to be an important moderator of treatment outcomes in BD, and QoL may be a 
particularly apposite index for outcomes in early and late stages of BD, where the classic 
episodic form of BD is less prominent. Mindfulness-based interventions target important 
vulnerabilities in BD, and are potentially useful across all stages of the disorder. Because of 
their transdiagnostic wellbeing focus, the study of MBIs will benefit from attention to QoL 
outcomes.  Further research into recovery-oriented interventions for BD will benefit 
recovery-oriented mental health services by building an evidence-base for congruent 
interventions, and refresh psychosocial approaches to BD by encouraging a humanistic focus 
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Table 1: Proposed mechanisms of mindfulness potentially relevant to BD 
Mechanism Exemplary 
instructions 
Relevance to BD Clinical implications of 





on the chosen 
object; whenever 
distracted, returning 
attention gently to 
the object 
Deficits in neurocognition 
(including executive attention) 
may be an endophenotype for 
BD (Sepede et al., 2012), 
worsen across the course (Berk 
et al., 2013) and impact emotion 
regulation (Van Rheenen & 
Rossell, 2013a) and functional 
outcomes (Martínez-Arán et al., 
2011). Mindfulness strengthens 
attention regulation, increases 
activation in the anterior 
cingulate cortex (Tang et al., 
2007; Xue, Tang, & Posner, 
2011), and improves cognition 
in BD (Stange et al., 2011)  
Potential to remediate 




with consequent benefits 
for QoL 
Body awareness Focus is usually an 




and other bodily 
sensations 
Theory of mind and social 
cognition deficits in BD (Cusi, 
Nazarov, Holshausen, 
Macqueen, & McKinnon, 2012; 
Van Rheenen & Rossell, 2013b) 
may arise from insufficient 
body awareness (Damasio, 
1999) underpinned by abnormal 
insula activity  (Malhi et al., 
2008) 
Potential to improve 




and dampening of 
positive emotions (Edge 
et al., 2013). Potential to 
improve empathic 
awareness with benefits 







Emotion regulation deficits well 
characterised in BD (Gruber, 



















Relevance to BD Clinical implications of 
mindfulness practice in 
BD 
reappraisal reactions in a non-
judgemental way 
Kogan, Mennin, & Murray, 
2013). Emotion regulation 
efforts are elevated (Gruber, 
Harvey, & Gross, 2012), but 
skills around reappraisal seem 
deficient (Heissler et al., 2014) 
through ‘non-appraisal’.  
QoL may be improved 
by consequent tolerance 
of the range of pleasant 
and unpleasant emotions 






Exposing oneself to 
whatever is present 
in the phenomenal 




Comorbid anxiety common in 
BD and impacts treatment 
response and course 
(Deckersbach et al., 2013).  
Exposure in the context of 
parasympathetic arousal 
facilitates extinction of negative 
emotions (Chambless & 
Ollendick, 2001) 
Potential to moderate 
anxiety comorbidities 
and stress-related 
relapses by extinguishing 
learned anxiety 
responses and ‘amygdala 
hijack’ (Bechara, 2005).  
Manic and depressive 
relapse involve a 
spiralling of emotions 
and associated cognitive 
and behavioural loops   
(Johnson & Fulford, 
2009; Mansell & Pedley, 
2008). Like fear 
responses, associative 
components of these 
loops may be 





identification with a 
static sense of self 
Sense of self is problematic in 
BD (Inder et al., 2008; R. Lee et 
al., 2010; E. Michalak et al., 
2011), often involves self-





attachment to an 
ambiguous, overly-
negative or overly-


















Relevance to BD Clinical implications of 
mindfulness practice in 
BD 
static self (Holzel et al., 
2011).  Mindfulness is 
also strongly linked to 




and QoL (Deckersbach, 















Table 2:  Studies investigating mindfulness-based therapies for bipolar disorder  
Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 


























- At least 18 
weeks of 
MBCT 
- Participants had a 
clearer awareness of 
their mood state and 
were able to better 
focus on the present, 
were more accepting 
of their mood state, 
were able to better 
practice mindfulness 
in different mood 
states, stabilise 
negative affect, relate 
differently to negative 
thoughts and reduce 
the impact of their 
current mood state. 
- Detailed information 
- Identification of 
different aspects of 
mindfulness 
influenced in BD 
- Limited 
generalizability 
- Two researchers  
involved in coding 
process (discrepancy) 
- Reported subjective 
benefits but not clinical 
- No control group 
Deckersbac










- Assessed pre-, 
post- and 3 
months 
following 
- 12 group 
sessions of 
MBCT 
- Post treatment and at 
the 3-month follow up 
participants reported 
increased mindfulness, 
- Assessment of a 
number of domains 
associated with 
mindfulness in BD 
- No control group 














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 






































and controls, at 










- EEG recording 









- 8 weeks of 
MBCT 










- Novel, objective 
measure (EEG) of 
mindfulness influence 
on BD  
- Small sample 
- Medication effects on 
brain patterns not 
controlled for 
- Control group did not 
undergo MBCT 














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 
Findings Strengths Limitations 
task and the 





- t-tests of EEG 
recordings 
- MBCT in euthymic 




































- EEG and ECG 












- 8 weeks of 
MBCT  
- At baseline 
participants with BD 
had exaggerated 
ERP N170 amplitude 
and increased HRV 
HF peak compared to 
control 
 
- After MBCT 
intervention 
participants with BD 
showed attenuation of 
ERP N170 amplitude 
- Novel, objective 
measures (ERP, HRV) 
of mindfulness 
influence on BD 
- Small sample  
- Medication effects on 
brain patterns not 
controlled for 
- Control group did not 
undergo MBCT 














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 
Findings Strengths Limitations 




tests of EEG and 
ECG recordings 









Investigated  the 
effects on 











- All patients 
underwent  
fMRI prior to 
MBCT 
treatment 
- 16 then 
underwent 
MBCT 
treatment and 7 
were wait listed 





- Region of 
interest and 
whole brain 
- 8 week 
MBCT 
- Post MBCT, Patients 





regulation, and in tests 
of working memory, 
spatial memory and 
verbal fluency. 
Activations in medial 
PFC (a region 
associated with 
cognitive flexibility 
and implicated in BD) 
also increased in 
patients post MBCT  
- Novel and multiple 
different measures 
(fMRI, neuropsych 
tests) of mindfulness 
influence on BD  
- BD and healthy 
control groups 
- Small sample  
















Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 


























- All measures 




- 8 week 
MBCT 




and suicidal ideation, 
and to a lesser extent, 
manic symptoms and 
anxiety. 
- Examined mania as 




- No control group 
- Patients underwent 
MBCT at different times 
of year and in four 
different groups 























- Meditation - A greater number of 
days spent meditating 
during the MBCT 
program was related to 
lower depression 
- Follow-up analysis 
- Examined mania 
- Examined in detail a 
specific component of 
MBCT 
- Small sample 
-No healthy control 
group 
- Only assessed one 














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 
Findings Strengths Limitations 




















and 9 in 
























was also related to 
improvements in 
depression and anxiety 
symptoms if a certain 
minimum amount (3 
times a week or more) 
throughout the MBCT 
program. 
- Type of meditation not 
assessed 











- 8 week 
MBCT + 
- MBCT was 
associated with a 
- Used RCT design 
- Mid and numerous 
- Small sample  














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 







plus TAU to 
TAU alone on 
patients with 






























- All measures 
assessed pre, 
mid, post 
treatment and at 
TAU reduction in anxiety 
symptoms. 
- However MBCT did 
not have an effect on 
time to depressive or 
hypo/manic relapse, 
total number of 
episodes, or mood 




- Clinician and self-
report measures 
- Effect of medication 














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 
Findings Strengths Limitations 
3, 6, 9 and 12 
months follow-
up 
- Intention to 
treat analysis 

















































- Five participants 
showed clinical 
improvements in 
depression at end of 
therapy and 1 month 
follow up. 
 






- Multiple follow up 
visits 
- Case-series design 
 
- Participants attended 




-Therapist was also 














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 
Findings Strengths Limitations 
-Assessed pre, 
post and 1, 3 














an open pilot 
trial of MBCT 
in patients with 

















- Assessed pre, 
post and 3 
months 




reported in executive 
functioning, memory, 
and ability to initiate 
and complete tasks 
after MBCT. 
- These changes were 
correlated with 
increases in mindful, 
nonjudgemental 
observance and 
awareness of thoughts, 
- Novel exploration of 
cognitive functioning 
in relation to MBCT 
- Clinician and self-
report measures 
- Small sample  














Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 




sensations, but not 





























- Assessed pre, 
post and 3 
months 
- At least 4 
MBCT 
sessions 




- However patient 
evaluation of the 
treatment revealed 
benefits of MBCT. 
- Examined patient 
expectations and 
subjective reports 
- No control group 
- Small sample  
- Subjective reports may 
















Study Aim/Hypotheses Sample  Methodology Definition of 
mindfulness 










































- 8 week 
MBCT 
- Both groups who 
underwent MBCT 
showed reductions in 
residual depressive 
symptoms compared 
to those in the control 
condition. 
- Post MBCT 
outcomes showed 
improvements in in 
terms of anxiety 
symptoms which were 




- Novel suicidal 
population assessed 
- Used bipolar and 
unipolar participants 
- Small sample  
- Recruited participants 
with suicidal ideation, 
limiting generalizability  
- Only self-report 
symptoms measures 
used 
- No follow up 
- Changes to medication 
or lifestyle changes due 
to MBCT not assessed 
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- 12 sessions 
of DBT and 
psychoeducat
ion 
- No significant 
differences in 
depressive symptoms 






were reported by the 
DBT group. 
 
- The DBT group also 
had reduced 
emergency room visits 
and mental health 
related admissions in 
the six months 
following treatment. 




mindfulness as DBT 
for BD 
- No follow-up 
 
- Small sample  
 













-26 patients with a 
self-reported primary 
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treatment effectiveness of an 
online mindfulness-
based intervention 
targeting quality of life 
in late-stage BD 
diagnosis of BD with 6 
or more episodes of 
BD 
- No control group 
- Self-reported diagnosis 

















 While clinicians prioritise the person over their diagnosis, evidence-based psychosocial treatments for serious mental disorders such as 
bipolar disorder (BD) remain focused on symptoms of disorder, and aim to affect the course of illness.   
 The recovery paradigm reminds mental health clinicians/researchers that people with mental health diagnoses hold the same broad 
wellbeing and autonomy goals as others in the community.      
 Recovery-focused psychosocial interventions for BD should recognise person-centric outcome measures, particularly quality of life, and 
challenge a simple diagnostic framework.  One important qualification on binary diagnosis is recognition of stage-like characteristics: 
The meaning of BD is very different for people with little experience (one or two episodes) versus those with a long history where 
relapse prevention may be an unrealistic goal.   
 Mindfulness-based interventions target recognised vulnerabilities of BD, while having aims that go beyond symptom control to recognise 
values and flexible engagement with the environment. Preliminary evidence suggests these third wave interventions that are popular 
amongst clinicians and patients, warrant further investigation and tailoring across early, middle and late stages of BD.  
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